Skip to main content
Fig. 2 | Diagnostic Pathology

Fig. 2

From: Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary

Fig. 2

DFS and OS Kaplan–Meier analyses in ovarian LGSC. a and b No significant differences were found between patients with KRAS/BRAF mutations and those with wild-type KRAS/BRAF genes (P = 0.8076 for DFS, and P = 0.282 for OS). c and d Three KRAS mutation subtypes were not significantly correlated with DFS (c) or OS (d), but there was a favorable prognostic trend for KRAS G12D mutation compared with wild-type and G12 V mutation in OS (d)

Back to article page